Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Waters Corp price target raised to $358 on pharma demand outlook

EditorBrando Bricchi
Published 05/08/2024, 11:26 PM
WAT
-

On Wednesday, TD Cowen adjusted its price target for Waters Corporation (NYSE:WAT), a specialty measurement company, raising it to $358 from the previous target of $350. The firm maintained its Hold rating on the stock. This adjustment follows Waters Corp 's announcement of a modest revenue beat for the first quarter and a reiteration of its 2024 guidance, despite a forecasted weaker second quarter.

The company's stock closed 2% higher after the earnings report was released. Management's commentary highlighted that pharmaceutical budgets and orders have become more stable, and customer feedback indicates an improvement in demand from the pharmaceutical sector. Additionally, Waters Corp experienced a stronger performance in China, showing early signs of a turnaround.

However, the chemicals and industrial sectors were noted as weak, continuing to pose a risk. Despite uncertainties, the 2024 guidance was supported by the company's order book and customer relationship management system, aligning with historical patterns. Nevertheless, investors still have questions regarding the future performance.

Waters Corp's recent developments come in the context of the broader market's search for signs of stability in various sectors, with particular attention to the impact of global economic conditions on companies like Waters. The company's focus on analytical technologies for the life sciences industry makes its performance an indicator of trends within this specific market segment.

InvestingPro Insights

Following the recent earnings report and guidance reiteration by Waters Corporation (NYSE:WAT), insights from InvestingPro provide a deeper look into the company's valuation and performance metrics. With a market capitalization of $19.41 billion and a P/E ratio of 31.99, Waters Corp is trading at a high earnings multiple, which is slightly adjusted to 30.18 when looking at the last twelve months as of Q1 2024. This suggests that the market has robust expectations for the company's earnings potential.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

An InvestingPro Tip indicates that analysts have revised their earnings expectations downwards for the upcoming period, which could be a point of concern for potential investors. Additionally, the company's stock has experienced a significant price uptick of 27.46% over the last six months, indicating strong market sentiment. Despite this recent growth, the company does not pay a dividend, which may influence the investment strategy for income-focused shareholders.

For those considering an investment in Waters Corp, it's worth noting that the company operates with a moderate level of debt and is predicted by analysts to be profitable this year, having been profitable over the last twelve months. For more detailed analysis and additional InvestingPro Tips, including the company's trading patterns and debt management, visit https://www.investing.com/pro/WAT. To further assist your investment decisions, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro, where 6 more tips are available to enrich your market perspective.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.